Requirement for NF-κB in transcriptional activation of monocyte chemotactic protein 1 by Chlamydia pneumoniae in human endothelial cells

Infection and Immunity

Volumn 68, Issue 7, 2000, Pages 4282-4288

  Molestina, Robert E ^a   Miller, Richard D ^a   Lentsch, Alex B ^a   Ramirez, Julio A ^a   Summersgill, James T ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR; PARTHENOLIDE; PRIMER DNA; SESQUITERPENE;

ARTICLE; ATHEROSCLEROSIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTROPHORETIC MOBILITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UMBILICAL VEIN; ARTERIOSCLEROSIS; CELL CULTURE; CHLAMYDIA TRACHOMATIS; DRUG ANTAGONISM; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; NUCLEOTIDE SEQUENCE; PATHOGENICITY; TRANSACTIVATION; VASCULAR ENDOTHELIUM;

ARTERIOSCLEROSIS; BASE SEQUENCE; CELLS, CULTURED; CHEMOKINE CCL2; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; DNA PRIMERS; ENDOTHELIUM, VASCULAR; HUMANS; NF-KAPPA B; RNA, MESSENGER; SESQUITERPENES; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS);

EID: 0033625591     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.7.4282-4288.2000     Document Type: Article

References (43)

1. Airenne, S., H.-M. Surcel, H. Alakärppä, K. Laitinen, J. Paavonen, P. Saikku, and A. Laurila. 1999. Chlamydia pneumoniae infection in human monocytes. Infect. Immun. 67:1445-1449.
2. Baggiolini, M. 1993. Chemotactic and inflammatory cytokines - CXC and CC proteins. Adv. Exp. Med. Biol. 353:1-10.
3. Campbell, L. A., C.-C. Kuo, and J. T. Grayston. 1998. Chlamydia pneumoniae and cardiovascular disease. Emerg. Infect. Dis. 4:571-579.
4. Collins, T. 1993. Endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab. Investig. 68:499-508.
5. Dechend, R., M. Maass, J. Gieffers, R. Dietz, C. Scheidereit, A. Leutz, and D. C. Gulba. 1999. Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-κB and induces tissue factor and PAI-1 expression. Circulation 100:1369-1373.
6. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1488.
7. Fong, I. W., B. Chiu, E. Viira, M. W. Fong, D. Jang, and J. Mahony. 1997. Rabbit model for Chlamydia pneumoniae infection. Infect. Immun. 35: 48-52.
8. Gaydos, C. A., D. G. Pham, and T. C. Quinn. 1996. Chlamydia pneumoniae infections in macrophages and coronary artery endothelial cells, p. 223. In A. Stary (ed.), Proceedings of the Third Meeting of the European Society for Chlamydia Research. Società Editrice Esculapio, Bologna, Italy.
9. Gaydos, C. A., J. T. Summersgill, N. N. Sahney, J. A. Ramirez, and T. C. Quinn. 1996. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect. Immun. 64:1614-1620.
10. Godzik, K. L., E. R. Obrien, S. K. Wang, and C.-C. Kuo. 1995. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J. Clin. Microbiol. 33:2411-2414.
11. Gosling, J., S. Slaymaker, L. Gu, S. Tseng, and C. H. Zlot. 1999. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J. Clin. Investig. 103:773-778.
12. Grayston, J. T. 1992. Chlamydia pneumoniae strain TWAR pneumonia. Annu. Rev. Med. 43:317-323.
13. Grayston, J. T., M. B. Aldous, A. Easton, S.-P. Wang, C.-C. Kuo, L. A. Campbell, and J. Altman. 1993. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J. Infect. Dis. 168:1231-1235.
14. Gu, L., Y. Okada, S. K. Clinton, C. Gerard, and G. K. Sukhova. 1998. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell 2:275-281.
15. Hammerschlag, M. R., K. Chirgwin, P. M. Roblin, M. Gelling, W. Dumornay, L. Mandel, P. Smith, and J. Schachter. 1992. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin. Infect. Dis. 14:178-182.
16. Hehner, S. P., M. Heinrich, P. M. Bork, M. Vogt, and F. Ratter. 1998. Sesquiterpene lactones specifically inhibit activation of NF-κB by preventing the degradation of IκB-α and IκB-β. J. Biol. Chem. 273:1288-1297.
17. Heinemann, M., M. Susa, V. Simnacher, R. Marre, and A. Essig. 1996. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect. Immun. 64: 4872-4875.
18. Hu, H., G. N. Pierce, and G. Zhong. 1999. The atherogenic effects of Chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J. Clin. Investig. 103:747-753.
19. Kalayoglu, M. V., and G. I. Byrne. 1998. Induction of macrophage foam cell formation by Chlamydia pneumoniae. J. Infect. Dis. 177:725-729.
20. Karkhanis, Y. D., J. Y. Zeltner, J. J. Jackson, and D. J. Carlo. 1978. A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of gram-negative bacteria. Anal. Biochem. 85:595-601.
21. Knudsen, K., A. S. Madsen, P. Mygind, G. Christiansen, and S. Birkelund. 1999. Identification of two novel genes encoding 97- to 99-kilodalton outer membrane proteins of Chlamydia pneumoniae. Infect. Immun. 67: 375-383.
22. Kol, A., G. K. Sukhova, A. H. Lichtman, and P. Libby. 1998. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-α and matrix metalloproteinase expression. Circulation 98:300-307.
23. Kol, A., T. Bourcier, A. H. Lichtman, and P. Libby. 1999. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J. Clin. Investig. 103:571-577.
24. Krüll, M., A. C. Klucken, F. N. Wuppermann, O. Fuhrmann, C. Magerl, J. Seybold, S. Hippenstiel, J. H. Hegemann, C. A. Jantos, and N. Suttorp. 1999. Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae. J. Immunol. 162:4834-4841.
25. Laitinen, K., A. Laurila, L. Pyhala, M. Leinonen, and P. Saikku. 1997. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect. Immun. 65:4832-4835.
26. Lentsch, A. B., T. P. Shanley, V. Sarma, and P. A. Ward. 1997. In vivo suppression of NF-κB and preservation of IκBα by interleukin-10 and interleukin-13. J. Clin. Investig. 100:2443-2448.
27. Martin, T., P. M. Cardarelli, G. C. N. Parry, K. A. Felts, and R. R. Cobb. 1997. Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-κB and AP-1. Eur. J. Immunol. 27:1091-1097.
28. May, M. J., and S. Ghosh. 1998. Signal transduction through NF-κB. Immunol. Today 19:80-88.
29. Mehta, S. J., R. D. Miller, J. A. Ramirez, and J. T. Summersgill. 1998. Inhibition of Chlamydia pneumoniae replication in HEp-2 cells by interferon-γ: role of tryptophan catabolism. J. Infect. Dis. 177:1326-1331.
30. Melnick, S. L., E. Shahar, A. R. Folsom, J. T. Grayston, P. D. Sorlie, S.-P. Wang, and M. Szklo. 1993. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Am. J. Med. 95:499-504.
31. Molestina, R. E., D. Dean, R. D. Miller, J. A. Ramirez, and J. T. Summersgill. 1998. Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells. Infect. Immun. 66:1370-1376.
32. Molestina, R. E., R. D. Miller, J. A. Ramirez, and J. T. Summersgill. 1999. Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes. Infect. Immun. 67:1323-1330.
33. Morrison, R. P., K. Lyng, and H. D. Caldwell. 1989. Chlamydial disease pathogenesis: ocular hypersensitivity elicited by a genus-specific 57-kD protein. J. Exp. Med. 169:663-675.
34. Parry, G. C. N., and N. Mackman. 1994. A set of inducible genes expressed by activated human monocytic and endothelial cells contain KκB-like sites that specifically bind c-Rel-p65 heterodimers. J. Biol. Chem. 269:20823-20825.
35. Ramirez, J. A., and the Chlamydia pneumoniae/Atherosclerosis Study Group. 1996. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann. Intern. Med. 125:979-982.
36. Rasmussen, S. J., C. K. Sen, and R. S. Stephens. 1998. Temporal expression of interleukin-8 in Chlamydia-infected epithelial cells, p. 411-414. In R. S. Stephens, G. I. Byrne, G. Christiansen, I. N. Clarke, J. T. Grayston, R. G. Rank, G. L. Ridgway, P. Saikku, J. Schachter, and W. E. Stamm (ed.), Proceedings of the Ninth International Symposium on Human Chlamydial Infection. University of California Printing Services, Berkeley, Calif.
37. Ross, R. 1999. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340:115-126.
38. Saikku, P., K. Mattila, M. S. Nieminen, P. H. Makela, J. K. Huttunen, and V. Valtonen. 1988. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet ii:983-986.
39. Saikku, P., M. Leinonen, L. Tenkanen, M. R. Ekman, E. Linnanmäki, V. Manninen, M. Mänttäri, M. H. Frick, and J. K. Huttunen. 1992. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann. Intern. Med. 116:273-278.
40. Saikku, P. 1997. Chlamydia pneumoniae and atherosclerosis - an update. Scand. J. Infect. Dis. Suppl. 104:53-56.
41. Schmitz, M. L., and P. A. Baeuerle. 1991. The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J. 10:3805-3817.
42. Shyy, Y.-J., Y.-S. Li, and P. E. Kolattukudy. 1993. Activation of MCP-1 gene expression is mediated through multiple signaling pathways. Biochem. Biophys. Res. Commun. 192:693-699.
43. Taylor-Robinson, D., and B. J. Thomas. 1998. Chlamydia pneumoniae in arteries: the facts, their interpretation, and future studies. J. Clin. Pathol. 51:793-797.